Travere Therapeutics (TVTX) Notes Payables (2011 - 2015)

Travere Therapeutics has reported Notes Payables for 3 years, with the latest figure at $41.1 million in Q2 2015.

• For the quarter ending Q2 2015, Notes Payables changed N/A year-over-year to $41.1 million; the trailing twelve-month figure through Jun 2015 stood at $41.1 million (changed N/A YoY), and the FY2014 full-year result was $40.5 million, changed N/A from the prior year.
• Notes Payables for Q2 2015 stood at $41.1 million, up from $40.5 million in the prior quarter.
• The five-year high for Notes Payables was $41.1 million in Q2 2015, with the low at $25.0 million in Q1 2011.
• Historically, Notes Payables has averaged $32.9 million across 3 years, with a median of $32.7 million in 2011.